Modulation of c-jun using inhibitors of protein kinase C

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6300320
SERIAL NO

09225749

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and compositions are provided for modulating c-jun expression using inhibitors of PKC-.alpha.. In preferred embodiments, the specific inhibitors are antisense oligonucleotides hybridizable to PKC-.alpha.. In preferred embodiments, the oligonucleotides contain one or more chemical modifications. Methods of modulating c-jun expression and of treating animals suffering from disease amenable to therapeutic intervention by modulating c-jun expression are disclosed

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ISIS PHARMACEUTICALS INC1896 RUTHERFORD ROAD CARLSBAD CA 92008

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dean, Nicholas M Olivenhain, CA 126 2851
McKay, Robert La Mesa, CA 102 2107

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation